Navigation Links
Lota Zoth Elected to Ikaria Board and Named Audit Committee Chair

CLINTON, N.J., Jan. 22 /PRNewswire/ -- Ikaria Holdings, Inc., a fully integrated critical care biopharmaceutical company, announced today that Lota S. Zoth has been elected as an independent member of the company's Board of Directors. Ms. Zoth, the former Chief Financial Officer of MedImmune, will chair the Ikaria Audit Committee.

"We are very fortunate to have an executive with Lota's background and qualifications joining our Board at a very important time in the company's history," said David Shaw, Chairman of the Ikaria Board of Directors. "Lota's deep understanding of financial and accounting issues, in addition to her senior leadership experience in the pharmaceutical business, make her a superb fit for Ikaria."

Ms. Zoth served as MedImmune's Chief Financial Officer from 2004 until mid 2007, when MedImmune was acquired by AstraZeneca. Prior to that, Ms. Zoth served as Chief Accounting Officer of MedImmune, PSINet and Sodexho Marriott, all publicly traded companies. Ms. Zoth began her career as an auditor with Ernst & Young, and went on to management positions in financial reporting and controllership at PepsiCo and Marriott International. Ms. Zoth is a CPA, and holds a BBA, summa cum laude, in accounting from Texas Tech University.

About Ikaria Holdings, Inc.

Ikaria Holdings, Inc. is a fully integrated biotherapeutics company focused on the development and commercialization of innovative in-hospital pharmaceutical products and drug/device combinations for the critically ill. The company's product, INOmax(R) (nitric oxide) for inhalation, is an FDA- approved drug for the treatment of hypoxic respiratory failure in term and near-term newborns. The drug also is approved by regulatory authorities and used in Canada, Europe, Australia and Latin America. In addition to marketing and selling its INOmax product, Ikaria is engaged in both Phase II trials with Covox(R) (carbon monoxide) for inhalation and Phase I trials with hydrogen sulfide (H2S) for various indications. Ikaria has a staff of over 300 people and is headquartered in Clinton, NJ, with research facilities in Seattle, WA and Madison, WI and manufacturing in Port Allen, LA. For more information on Ikaria, please visit


Elizabeth Larkin Jason Rando

Ikaria The Ruth Group

908-238-6645 646-536-7025

SOURCE Ikaria Holdings, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Bruce Pasternack Elected to Codexis Board
2. Biomaxx Systems Inc. Selected as Technical Consultant By Southern Cross Agricultural Developments
3. Solazyme, Inc. Selected by AlwaysOn as a GoingGreen 100 Top Private Company Award Winner
4. Total Site Solutions Selected to Provide Construction Management Services for Existing Pharmaceutical and Biotech Customer for Data Center Expansion Project
5. AG Mednet Selected By Massachusetts General Hospital to Transport 3D Post-Processing Images
6. Medivation Selected as Founding Member of New NASDAQ(R) NeuroInsights(R) Neurotech Index
7. Arena Pharmaceuticals Selected to Join New NASDAQ NeuroInsights Neurotech Index
8. Solazyme Selected for National Institute of Standards and Technology Award
9. Advanced Life Sciences to Present Data from Selected Cethromycin Clinical Trials at the 45th Annual Meeting of the Infectious Diseases Society of America
10. Genstructs Andrea Matthews Selected for Mass High Techs People to Watch Under 30
11. Thomson Scientific Salutes Nobel Laureate Prize Winners, Many of Whom Were Selected as Thomson Scientific Laureates in 2006
Post Your Comments:
(Date:11/25/2015)... Nov. 25, 2015 Orexigen® Therapeutics, Inc. (Nasdaq: ... in a fireside chat discussion at the Piper Jaffray ... . The discussion is scheduled for Wednesday, December ... .  A replay will be available for 14 ... , Julie NormartVP, Corporate Communications and Business Development ...
(Date:11/24/2015)... ... November 24, 2015 , ... The United States Golf Association ... 2016 USGA Green Section Award. Presented annually since 1961, the USGA Green Section Award ... work with turfgrass. , Clarke, of Iselin, N.J., is an extension specialist ...
(Date:11/24/2015)... ... November 24, 2015 , ... Copper is ... it is bound to proteins, copper is also toxic to cells. With a ... Polytechnic Institute (WPI) will conduct a systematic study of copper in the bacteria ...
(Date:11/24/2015)... 2015 --> ... "Oligonucleotide Synthesis Market by Product & Services (Primer, Probe, ... DNA, RNAi), End-User (Research, Pharmaceutical & Biotech, Diagnostic Labs) ... market is expected to reach USD 1,918.6 Million by ... CAGR of 10.1% during the forecast period. ...
Breaking Biology Technology:
(Date:10/29/2015)... LA JOLLA, Calif. , Oct. 29, 2015 /PRNewswire-USNewswire/ ... released a new report titled, "DNA Synthesis and Biosecurity: ... how well the Department of Health and Human Services ... was issued in 2010. --> ... advances, but it also has the potential to pose ...
(Date:10/29/2015)... 29, 2015 NXTD ) ... focused on the growing mobile commerce market and ... StackCommerce, a leading marketplace to discover and buy ... smart wallet on StackSocial for this holiday season. ... the "Company"), a biometric authentication company focused on ...
(Date:10/27/2015)... , Oct. 27, 2015 Synaptics Inc. (NASDAQ: ... today announced that Google has adopted the Synaptics ® ... controller solutions to power its newest flagship smartphones, the ... Huawei. --> --> ... Google to provide strategic collaboration in the joint development ...
Breaking Biology News(10 mins):